Advertisement
U.S. markets open in 2 hours 42 minutes

Navidea Biopharmaceuticals, Inc. (NAVB)

Other OTC - Other OTC Delayed Price. Currency in USD
0.03710.0000 (0.00%)
At close: 03:25PM EDT
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0.61
14.645
45.615
118.725
Cost of Revenue
50.036
184.947
0
1.048
Gross Profit
-49.426
-170.302
45.615
117.677
Operating Expense
10,130
13,881
12,106
10,829
Operating Income
-10,180
-14,051
-12,060
-10,711
Net Non Operating Interest Income Expense
3.051
-1,098
-6.361
11.344
Other Income Expense
1,569
-27.939
351.885
-21.854
Pretax Income
-8,607
-15,177
-11,715
-10,722
Tax Provision
-
0
16.043
0
Net Income Common Stockholders
-1,389
-17,215
-11,731
-11,386
Diluted NI Available to Com Stockholders
-1,389
-17,215
-11,731
-11,386
Basic EPS
-0.08
-0.56
-0.40
-0.48
Diluted EPS
-0.08
-0.56
-0.40
-0.48
Basic Average Shares
53,347
30,902
29,344
23,896
Diluted Average Shares
53,347
30,902
29,344
23,896
Total Operating Income as Reported
-10,180
-14,051
-12,060
-10,711
Total Expenses
10,180
14,066
12,106
10,830
Net Income from Continuing & Discontinued Operation
-1,182
-15,177
-11,731
-10,722
Normalized Income
-9,172
-15,177
-11,998
-10,722
Interest Income
-
-
-
11.344
Interest Expense
-
1,098
6.361
-
Net Interest Income
3.051
-1,098
-6.361
11.344
EBIT
-10,208
-14,079
-11,709
-10,711
EBITDA
-10,099
-13,983
-11,632
-10,641
Reconciled Cost of Revenue
50.036
184.947
0
1.048
Reconciled Depreciation
108.184
95.819
76.954
70.393
Net Income from Continuing Operation Net Minority Interest
-8,607
-15,177
-11,731
-10,722
Total Unusual Items Excluding Goodwill
564.944
0
366
0
Total Unusual Items
564.944
0
366
0
Normalized EBITDA
-10,664
-13,983
-11,998
-10,641
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
98.82
0